Cargando…

Tigecycline use in serious nosocomial infections: a drug use evaluation

BACKGROUND: Tigecycline is a novel antibiotic with activity against multidrug resistant bacteria. The aim of this study was to assess the efficacy of tigecycline use in serious hospital-acquired infections (HAI) CASE PRESENTATION: Prospective observational study of tigecycline use was conducted in a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bassetti, Matteo, Nicolini, Laura, Repetto, Ernestina, Righi, Elda, Del Bono, Valerio, Viscoli, Claudio
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2956728/ https://www.ncbi.nlm.nih.gov/pubmed/20920273 http://dx.doi.org/10.1186/1471-2334-10-287

Ejemplares similares

Epidemiological trends in nosocomial candidemia in intensive care
por: Bassetti, Matteo, et al.
Publicado: (2006)

Epidemiology, Species Distribution, Antifungal Susceptibility and Outcome of Nosocomial Candidemia in a Tertiary Care Hospital in Italy
por: Bassetti, Matteo, et al.
Publicado: (2011)

Issues in the management of invasive pulmonary aspergillosis in non-neutropenic patients in the intensive care unit: A role for isavuconazole
por: Bassetti, Matteo, et al.
Publicado: (2018)

Multidrug resistant Acinetobacter nosocomial meningitis treated successfully with parenteral tigecycline
por: Wadi, Jamal Ahmad, et al.
Publicado: (2007)

Bench-to-bedside review: Therapeutic management of invasive candidiasis in the intensive care unit
por: Bassetti, Matteo, et al.
Publicado: (2010)

Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin
por: Righi, Elda, et al.
Publicado: (2018)

Invasive Candidiasis in Non-Hematological Patients
por: Mikulska, Malgorzata, et al.
Publicado: (2011)

How to manage Pseudomonas aeruginosa infections
por: Bassetti, Matteo, et al.
Publicado: (2018)

Rational use of tigecycline and tigecycline blood concentration monitoring in patients with severe infection
por: Yu, Meiling, et al.
Publicado: (2023)

Can Neutrophils Prevent Nosocomial Pneumonia after Serious Injury?
por: Macáková, Kristína, et al.
Publicado: (2023)

Clinical and Therapeutic Aspects of Candidemia: A Five Year Single Centre Study
por: Bassetti, Matteo, et al.
Publicado: (2015)

Identification of a New Delhi metallo-β-lactamase-4 (NDM-4)-producing Escherichia coli in Italy
por: Coppo, Erika, et al.
Publicado: (2014)

High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A retrospective cohort study
por: Geng, Ting-Ting, et al.
Publicado: (2018)

High-dose tigecycline use in severe infections
por: De Pascale, G, et al.
Publicado: (2013)

Bacillus cereus, a serious cause of nosocomial infections: Epidemiologic and genetic survey
por: Glasset, Benjamin, et al.
Publicado: (2018)

Tigecycline Immunodetection Using Developed Group-Specific and Selective Antibodies for Drug Monitoring Purposes
por: Galvidis, Inna A., et al.
Publicado: (2023)

Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay
por: Portell-Buj, Elena, et al.
Publicado: (2021)

A Global View to HBV Chronic Infection: Evolving Strategies for Diagnosis, Treatment and Prevention in Immunocompetent Individuals
por: Nicolini, Laura Ambra, et al.
Publicado: (2019)

Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004–2013
por: Hoban, Daryl J, et al.
Publicado: (2015)

Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic country
por: Bassetti, Matteo, et al.
Publicado: (2016)

Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts
por: Corte, Laura, et al.
Publicado: (2016)

Drugs of Last Resort? The Use of Polymyxins and Tigecycline at US Veterans Affairs Medical Centers, 2005–2010
por: Huttner, Benedikt, et al.
Publicado: (2012)

Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature
por: Mirabella, Michele, et al.
Publicado: (2018)

Possible Clinical Failure of Artemether-Lumefantrine in an Italian Traveler with Uncomplicated Falciparum Malaria.
por: Repetto, Ernestina C., et al.
Publicado: (2011)

Tigecycline Susceptibility and the Role of Efflux Pumps in Tigecycline Resistance in KPC-Producing Klebsiella pneumoniae
por: He, Fang, et al.
Publicado: (2015)

Comparison between procalcitonin and C-reactive protein to predict blood culture results in ICU patients
por: Bassetti, Matteo, et al.
Publicado: (2018)

Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study
por: Viscoli, Claudio, et al.
Publicado: (2014)

The Antibiotic Drug Tigecycline: A Focus on its Promising Anticancer Properties
por: Xu, Zhijie, et al.
Publicado: (2016)

Tigecycline-induced Drug Fever and Leukemoid Reaction: A Case Report
por: Shao, Qian-Qian, et al.
Publicado: (2015)

Tigecycline Induced Hyperpigmentation of the Skin
por: Vandecasteele, S. J., et al.
Publicado: (2016)

Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a 8-year retrospective study in a large teaching hospital in northern Italy
por: Alicino, Cristiano, et al.
Publicado: (2015)

A Novel Tigecycline Adjuvant ML-7 Reverses the Susceptibility of Tigecycline-Resistant Klebsiella pneumoniae
por: Sun, Lilan, et al.
Publicado: (2022)

Clinical effectiveness of tigecycline in combination therapy against nosocomial pneumonia caused by CR-GNB in intensive care units: a retrospective multi-centre observational study
por: Yang, Kuang-Yao, et al.
Publicado: (2023)

Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality
por: Bassetti, Matteo, et al.
Publicado: (2017)

Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions
por: Righi, Elda
Publicado: (2018)

Once Daily High Dose Tigecycline Is Optimal: Tigecycline PK/PD Parameters Predict Clinical Effectiveness
por: Baron, Jeffrey, et al.
Publicado: (2018)

First Emergence of acrAB and oqxAB Mediated Tigecycline Resistance in Clinical Isolates of Klebsiella pneumoniae Pre-Dating the Use of Tigecycline in a Chinese Hospital
por: Zhong, Xue, et al.
Publicado: (2014)

Acinetobacter Prosthetic Joint Infection Treated with Debridement and High-Dose Tigecycline
por: Vila, Andrea, et al.
Publicado: (2016)

Use of Carbapenems, Polymyxins, and Tigecycline in United States Children’s Hospitals, 2010–2014
por: Chiotos, Kathleen, et al.
Publicado: (2017)

Effects of tigecycline and doxycycline in porcine endotoxemia
por: Von Seth, M, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_t59ro5jb3rhqkp26ngv8j8gbdg